Formulation Development is a key element in the pharmaceutical development process. There is an increasing trend by companies to outsource not just this service, but an integrated platform of ...

TAMPA, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Inhibitor Therapeutics, Inc. (OTCQB: INTI) ("Inhibitor" or the "Company"), today provided an update on its ongoing pharmacokinetic (PK) clinical program ...

Conventional manufacturing of dosage forms for small molecule drugs in centralized facilities is not well-suited to meet the needs of adaptive clinical trials for early-phase dose escalation and ...

ALBANY, New York, Jan. 19, 2015 /PRNewswire/ -- AMRI (AMRI) today announced it received a 10-year federal contract award from the National Institutes of Health (NIH) for drug development and ...

Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies New ...

The success of the mRNA vaccines for COVID-19 led to explosive growth in lipid nanoparticle (LNP)-mediated drug delivery for RNA vaccines and therapeutics. As these projects scale into clinical trials ...

Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer. Cytostatic ...

Opportunities span preventive health, stable formulations for food, supplements and pharma, animal nutrition, dermatology, cosmetics and sports nutritionDublin, Sept. 03, 2026 (GLOBE NEWSWIRE) -- The ...

Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the first new FDA-approved treatment for fibromyalgia in ...

Lorenol Labs announces relaunch with refined skincare and new product innovations, with a strong push into education and medical partnerships. Naples, Florida, United States, August 4, 2026-- Lorenol ...